Intervention Review

Pre and peri-operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.

  1. Karen M Devon1,*,
  2. Robin S McLeod2

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 30 OCT 2008

DOI: 10.1002/14651858.CD007148.pub2

Database Title

Additional Information

How to Cite

Devon KM, McLeod RS. Pre and peri-operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007148. DOI: 10.1002/14651858.CD007148.pub2.

Author Information

  1. 1

    University of Toronto, Mount Sinai Hospital, Department of Surgery, Toronto, Ontario, Canada

  2. 2

    Mount Sinai Hospital, Division of General Surgery, Toronto, Ontario, Canada

*Karen M Devon, Department of Surgery, University of Toronto, Mount Sinai Hospital, 600 University Ave. Suite 449, c/o Dr. R.S. McLeod, Toronto, Ontario, Canada. karen.devon@utoronto.ca. rmcleod@mtsinai.on.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (250K)Full (273K)

  1. Current Version

    Pre and peri-operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.

    Karen M Devon and Robin S McLeod

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD007148.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Pre and peri-operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.

    Karen M Devon and Robin S McLeod

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD007148

View Full Article (HTML) Summary (58K)Standard (250K)Full (273K)